These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8866970)

  • 1. 3-O-acetylmorphine-6-O-sulfate: a potent, centrally acting morphine derivative.
    Houdi AA; Kottayil S; Crooks PA; Butterfield DA
    Pharmacol Biochem Behav; 1996 Mar; 53(3):665-71. PubMed ID: 8866970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
    Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of morphine-like effects of the mixed mu/delta agonist morphine-6-
    Yadlapalli JSK; Bommagani SB; Mahelona RD; Wan A; Gannon BM; Penthala NR; Dobretsov M; Crooks PA; Fantegrossi WE
    Pharmacol Res Perspect; 2018 Jul; 6(4):e00403. PubMed ID: 29930811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Analgesia, Tolerance, and the Mechanism of Action of Morphine-6-O-Sulfate Across Multiple Pain Modalities in Sprague-Dawley Rats.
    Yadlapalli JSK; Dogra N; Walbaum AW; Wessinger WD; Prather PL; Crooks PA; Dobretsov M
    Anesth Analg; 2017 Sep; 125(3):1021-1031. PubMed ID: 28489639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of morphine-6-sulfate and codeine-6-sulfate.
    Zuckerman A; Bolan E; de Paulis T; Schmidt D; Spector S; Pasternak GW
    Brain Res; 1999 Sep; 842(1):1-5. PubMed ID: 10526089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the discriminative and antinociceptive effects of morphine and its glucuronide metabolites after central or systemic administration in the rat.
    Easterling KW; Holtzman SG
    Psychopharmacology (Berl); 1998 Nov; 140(1):91-7. PubMed ID: 9862407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of spatial orientation of the C-6-OH group in ring C of morphine derivatives on opioid activity.
    Friedmann T; Tóth Z; Hosztafi S; Simon CS; Makleit S; Fürst S
    Arch Int Pharmacodyn Ther; 1994; 328(1):16-25. PubMed ID: 7893188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical assessment of utility of M6S for multimodal acute and chronic pain treatment in diabetic neuropathy.
    Yadlapalli JSK; Dogra N; Walbaum AW; Prather PL; Crooks PA; Dobretsov M
    Life Sci; 2018 Jan; 192():151-159. PubMed ID: 29191644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability studies of potent opioid analgesic, morphine-6-O-sulfate in various buffers and biological matrices by HPLC-DAD analysis.
    Yadlapalli JSK; Albayati ZAF; Penthala NR; Hendrickson HP; Crooks PA
    Biomed Chromatogr; 2017 Sep; 31(9):. PubMed ID: 28205234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats.
    Abbott FV; Palmour RM
    Life Sci; 1988; 43(21):1685-95. PubMed ID: 2848167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacokinetic study of morphine-6-O-sulfate in rat plasma and brain.
    Yadlapalli JSK; Albayati ZAF; Breen PJ; Dobretsov M; Penthala NR; Hendrickson HP; Crooks PA
    Drug Dev Res; 2021 Sep; 82(6):802-814. PubMed ID: 33427316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine.
    Frances B; Gout R; Monsarrat B; Cros J; Zajac JM
    J Pharmacol Exp Ther; 1992 Jul; 262(1):25-31. PubMed ID: 1320685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal effect of morphine 6-glucuronide: in vivo and in vitro characterization.
    Massi P; Giagnoni G; Basilico L; Gori E; Rubino T; Parolaro D
    Eur J Pharmacol; 1994 Mar; 253(3):269-74. PubMed ID: 8200420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-beta-D-glucuronide in the rat.
    Stain F; Barjavel MJ; Sandouk P; Plotkine M; Scherrmann JM; Bhargava HN
    J Pharmacol Exp Ther; 1995 Aug; 274(2):852-7. PubMed ID: 7636748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potency ratios of morphine and morphine-6beta-glucuronide analgesia elicited from the periaqueductal gray, locus coeruleus or rostral ventromedial medulla of rats.
    Krzanowska EK; Rossi GC; Pasternak GW; Bodnar RJ
    Brain Res; 1998 Jul; 799(2):329-33. PubMed ID: 9675330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid receptor agonist potencies of morphine and morphine-6-glucuronide in the guinea-pig ileum.
    Schmidt N; Brune K; Geisslinger G
    Eur J Pharmacol; 1994 Apr; 255(1-3):245-7. PubMed ID: 8026550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of heroin and morphine self-administration in rats by the morphine-6beta-glucuronide antagonist 3-O-methylnaltrexone.
    Walker JR; King M; Izzo E; Koob GF; Pasternak GW
    Eur J Pharmacol; 1999 Oct; 383(2):115-9. PubMed ID: 10585524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine-6-glucuronide is more mu-selective and potent in analgesic tests than morphine.
    Francés B; Gout R; Campistron G; Panconi E; Cros J
    Prog Clin Biol Res; 1990; 328():477-80. PubMed ID: 2154808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
    Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
    Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.